Comac Medical has conducted an assessment in IMP³rove – an instrument provided by the European Commission for measurement of the innovation potential of the company, which ranked the company among the growth champions in Europe.
IMP³rove assessment
October 19, 2015
Share:
News
A perfect protocol and a well‑funded budget means very little if eligible volunteers never make it through the...
Sofia, Bulgaria, April 28, 2025 – Comac Medical, a leading full-service Contract Research Organization (CRO) in Central and Eastern Europe,...
Clinical trials are the backbone of medical advancements, they ensure that new treatments undergo rigorous evaluation for safety...